Daily Stock Setups

FAES FARMA signs licensing agreement with Pfizer for Bilastine

Posted on: Fri, 13 Nov 2009 14:12:00 EST

Symbols: PFE

Are you looking to increase your ETF knowledge?

Nov 13, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
PFE | Quote | Chart | News | PowerRating -- FAES FARMA, a Spanish pharmaceutical company, has signed a licensing agreement with Pfizer, Inc., a US-based biopharmaceutical company, to market the former's Bilastine antihistamine drug in Mexico.

Under the terms of the agreement, Pfizer has obtained the rights to commercialize Bilastine in Mexico. FAES retains the right to directly commercialize the product in Mexico, under co-marketing conditions.

Deal Type    Partnership
Sub-Category Licensing Agreement,Commercialization,Marketing
Deal Status  Announced: 2009-11-12

Deal Participants

Partner 1 (Company) FAES FARMA
Partner 2 (Company) Pfizer, Inc.

For full details on Pfizer Inc (PFE) PFE. Pfizer Inc (PFE) has Short Term PowerRatings at TradingMarkets. Details on Pfizer Inc (PFE) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Related News

Pfizer teams up to offer online health management - 02/09/10
Atrium's role at Pfizer growing - 02/09/10
BRIEF: Pfizer partners with interactive-technology firm to help boost health outcomes - 02/08/10
Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness - 02/08/10
BRIEF: Bristol-Myers freezing salaries - 02/06/10
More News >>

UPCOMING EVENTS

Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.

Thursday February 11 04:30 PM

Leveraged ETF Trading Course

Thursday February 11 12:30 PM

Hear What Kevin Haggerty Sees in the Stock Market Today!

Wednesday February 10 01:00 PM

Hear What Gary Kaltbaum Sees in the Stock Market Today!

* Attendance is strictly limited and are filled on a first-come, first-served basis.

PREMIER SPONSORED LINKS

TRADE CENTER

Recent Articles Market Analysis Stock Alerts Breaking News All News

About TradingMarkets Advertise Contact Careers Link to Us Help Terms & Conditions Privacy Policy Return Policy Testimonials Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.